{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T06:32:03Z","timestamp":1794983523162,"version":"4.9.1"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T00:00:00Z","timestamp":1747180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001350","name":"Ministry of Health -Singapore","doi-asserted-by":"publisher","award":["STaR18nov-0002"],"award-info":[{"award-number":["STaR18nov-0002"]}],"id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001459","name":"Ministry of Education - Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001459","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001381","name":"National Research Foundation, Singapore","doi-asserted-by":"crossref","award":["CIRG21nov-0009CIRG21nov-0009"],"award-info":[{"award-number":["CIRG21nov-0009CIRG21nov-0009"]}],"id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P01HL131477-01A1"],"award-info":[{"award-number":["P01HL131477-01A1"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P01 HL158688\/HL\/NHLBI NIH"],"award-info":[{"award-number":["P01 HL158688\/HL\/NHLBI NIH"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["P30 GM124165"],"award-info":[{"award-number":["P30 GM124165"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","award":["S10OD021527"],"award-info":[{"award-number":["S10OD021527"]}],"id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006224","name":"DOE | SC | Argonne National Laboratory","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006224","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Xiu Research Fund"},{"name":"Linde Family Foundation"},{"name":"AGA\/Jenzabar Research Fund"},{"DOI":"10.13039\/100001006","name":"Breast Cancer Research Foundation BCRF","doi-asserted-by":"crossref","award":["24-177"],"award-info":[{"award-number":["24-177"]}],"id":[{"id":"10.13039\/100001006","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["EMBO Mol Med"],"published-print":{"date-parts":[[2025,6,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Immunomodulatory imide drugs (IMiDs) degrade specific C2H2 zinc finger degrons in transcription factors, making them effective against certain cancers. SALL4, a cancer driver, contains seven C2H2 zinc fingers in three clusters, including an IMiD degron in zinc finger cluster one (ZFC1). Surprisingly, IMiDs do not inhibit the growth of SALL4-expressing cancer cells. To overcome this limit, we focused on a non-IMiD domain, SALL4 zinc finger cluster four (ZFC4). By combining ZFC4-DNA crystal structure and an in silico docking algorithm, in conjunction with cell viability assays, we screened several chemical libraries against a potentially druggable binding pocket, leading to the discovery of SH6, a compound that selectively targets SALL4-expressing cancer cells. Mechanistic studies revealed that SH6 degrades SALL4 protein through the CUL4A\/CRBN pathway, while deletion of ZFC4 abolished this activity. Moreover, SH6 treatment led to a significant 87% tumor growth inhibition of SALL4+ patient-derived xenografts and demonstrated good bioavailability in pharmacokinetic studies. In summary, these studies represent a new approach for IMiD independent drug discovery targeting C2H2 transcription factors such as SALL4 in cancer.<\/jats:p>","DOI":"10.1038\/s44321-025-00241-3","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T09:06:48Z","timestamp":1747213608000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Targeting transcription factors through an IMiD independent zinc finger domain"],"prefix":"10.1038","volume":"17","author":[{"given":"Bee Hui","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3365-0213","authenticated-orcid":false,"given":"Miao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sridhar","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Yuan","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5222-1137","authenticated-orcid":false,"given":"Chaitanya Kumar","family":"Jaladanki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8934-1586","authenticated-orcid":false,"given":"Chong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing Ping","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7092-9031","authenticated-orcid":false,"given":"Kalpana","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei Lin","family":"Go","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim Anh L","family":"Vu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsu","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0646-2102","authenticated-orcid":false,"given":"Hyuk-Soo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6037-9345","authenticated-orcid":false,"given":"Kijun","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-7363","authenticated-orcid":false,"given":"Justin L","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arek V","family":"Melkonian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaoji","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerburg","family":"Wulf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haribabu","family":"Arthanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirano","family":"Dhe-Paganon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G","family":"Clohessy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yeu Khai","family":"Choong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sivaraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6423-3888","authenticated-orcid":false,"given":"Daniel G","family":"Tenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1937-4750","authenticated-orcid":false,"given":"Li","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,14]]},"reference":[{"key":"241_CR1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1107\/S0907444909052925","volume":"66","author":"PD Adams","year":"2010","unstructured":"Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW et al (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66:213\u2013221","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"241_CR2","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/anie.201005959","volume":"50","author":"C Avonto","year":"2011","unstructured":"Avonto C, Taglialatela-Scafati O, Pollastro F, Minassi A, Di Marzo V, De Petrocellis L, Appendino G (2011) An NMR spectroscopic method to identify and classify thiol-trapping agents: revival of Michael acceptors for drug discovery? Angew Chem Int Ed Engl 50:467\u2013471","journal-title":"Angew Chem Int Ed Engl"},{"key":"241_CR3","volume":"13","author":"P Bryant","year":"2022","unstructured":"Bryant P, Pozzati G, Elofsson A (2022) Improved prediction of protein-protein interactions using AlphaFold2. Nat Commun 13:1265","journal-title":"Nat Commun"},{"key":"241_CR4","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/s41568-019-0196-7","volume":"19","author":"JH Bushweller","year":"2019","unstructured":"Bushweller JH (2019) Targeting transcription factors in cancer - from undruggable to reality. Nat Rev Cancer 19:611\u2013624","journal-title":"Nat Rev Cancer"},{"key":"241_CR5","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1021\/acschembio.7b00799","volume":"12","author":"SH Choi","year":"2017","unstructured":"Choi SH, Mahankali M, Lee SJ, Hull M, Petrassi HM, Chatterjee AK, Schultz PG, Jones KA, Shen W (2017) Targeted disruption of Myc-Max oncoprotein complex by a small molecule. ACS Chem Biol 12:2715\u20132719","journal-title":"ACS Chem Biol"},{"key":"241_CR6","unstructured":"ClinicalTrials.gov. (2019) Bethesda (MD): National Library of Medicine (US). Identifier NTC03888612. Trial of ARV-110 in patients with metastatic castration resistant prostate cancer (mCRPC). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03888612"},{"key":"241_CR7","unstructured":"ClinicalTrials.gov. (2019) Bethesda (MD): National Library of Medicine (US). Identifier NTC04072952. A phase 1\/2 trial of ARV-471 alone and in combination with palbociclib (IBRANCE\u00ae) in patients with ER+\/HER2- locally advanced or metastatic breast cancer (mBC). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT04072952"},{"key":"241_CR8","doi-asserted-by":"crossref","first-page":"e38430","DOI":"10.7554\/eLife.38430","volume":"7","author":"KA Donovan","year":"2018","unstructured":"Donovan KA, An J, Nowak RP, Yuan JC, Fink EC, Berry BC, Ebert BL, Fischer ES (2018) Thalidomide promotes degradation of SALL4, a transcription factor implicated in Duane Radial Ray syndrome. Elife 7:e38430","journal-title":"Elife"},{"key":"241_CR9","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","volume":"60","author":"P Emsley","year":"2004","unstructured":"Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics. Acta Crystallogr D Biol Crystallogr 60:2126\u20132132","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"241_CR10","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nature09504","volume":"468","author":"P Filippakopoulos","year":"2010","unstructured":"Filippakopoulos P, Qi J, Picaud S, Shen Y, Smith WB, Fedorov O, Morse EM, Keates T, Hickman TT, Felletar I et al (2010) Selective inhibition of BET bromodomains. Nature 468:1067\u20131073","journal-title":"Nature"},{"key":"241_CR11","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1002\/pro.4050","volume":"30","author":"TG Flower","year":"2021","unstructured":"Flower TG, Hurley JH (2021) Crystallographic molecular replacement using an in silico-generated search model of SARS-CoV-2 ORF8. Protein Sci 30:728\u2013734","journal-title":"Protein Sci"},{"key":"241_CR12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-18488-4","volume":"11","author":"H Furihata","year":"2020","unstructured":"Furihata H, Yamanaka S, Honda T, Miyauchi Y, Asano A, Shibata N, Tanokura M, Sawasaki T, Miyakawa T (2020) Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide. Nat Commun 11:4578","journal-title":"Nat Commun"},{"key":"241_CR13","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1182\/blood.V110.11.1591.1591","volume":"110","author":"JE Grembecka","year":"2007","unstructured":"Grembecka JE, Graf K, Kong Y, Douvas M, Cierpicki T, Illendula A, Baber G, Bielnicka I, Roudaia L, Speck NA et al (2007) Development of Small Molecule Inhibitors of the AML1-ETO and CBF\u03b2-SMMHC Oncoproteins. Blood 110:1591\u20131591","journal-title":"Blood"},{"key":"241_CR14","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41573-021-00199-0","volume":"20","author":"MJ Henley","year":"2021","unstructured":"Henley MJ, Koehler AN (2021) Advances in targeting \u2018undruggable\u2019 transcription factors with small molecules. Nat Rev Drug Discov 20:669\u2013688","journal-title":"Nat Rev Drug Discov"},{"key":"241_CR15","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundback T, Nordlund P, Martinez Molina D (2014) The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc 9:2100\u20132122","journal-title":"Nat Protoc"},{"key":"241_CR16","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/s41571-021-00479-z","volume":"18","author":"M Jan","year":"2021","unstructured":"Jan M, Sperling AS, Ebert BL (2021) Cancer therapies based on targeted protein degradation - lessons learned with lenalidomide. Nat Rev Clin Oncol 18:401\u2013417","journal-title":"Nat Rev Clin Oncol"},{"key":"241_CR17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, Zidek A, Potapenko A et al (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583\u2013589","journal-title":"Nature"},{"key":"241_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41592-021-01362-6","volume":"19","author":"J Jumper","year":"2022","unstructured":"Jumper J, Hassabis D (2022) Protein structure predictions to atomic accuracy with AlphaFold. Nat Methods 19:11\u201312","journal-title":"Nat Methods"},{"key":"241_CR19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1107\/S0907444909047374","volume":"66","author":"W Kabsch","year":"2010","unstructured":"Kabsch W (2010) Integration, scaling, space-group assignment and post-refinement. Acta Crystallogr D Biol Crystallogr 66:133\u2013144","journal-title":"Acta Crystallogr D Biol Crystallogr"},{"key":"241_CR20","first-page":"965","volume":"26","author":"D Kobayashi","year":"2011","unstructured":"Kobayashi D, Kuribayashi K, Tanaka M, Watanabe N (2011a) Overexpression of SALL4 in lung cancer and its importance in cell proliferation. Oncol Rep 26:965\u2013970","journal-title":"Oncol Rep"},{"key":"241_CR21","first-page":"933","volume":"38","author":"D Kobayashi","year":"2011","unstructured":"Kobayashi D, Kuribayshi K, Tanaka M, Watanabe N (2011b) SALL4 is essential for cancer cell proliferation and is overexpressed at early clinical stages in breast cancer. Int J Oncol 38:933\u2013939","journal-title":"Int J Oncol"},{"key":"241_CR22","volume":"34","author":"NR Kong","year":"2021","unstructured":"Kong NR, Bassal MA, Tan HK, Kurland JV, Yong KJ, Young JJ, Yang Y, Li F, Lee JD, Liu Y et al (2021) Zinc finger protein SALL4 functions through an AT-rich motif to regulate gene expression. Cell Rep. 34:108574","journal-title":"Cell Rep."},{"key":"241_CR23","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/prot.21117","volume":"65","author":"D Kozakov","year":"2006","unstructured":"Kozakov D, Brenke R, Comeau SR, Vajda S (2006) PIPER: an FFT-based protein docking program with pairwise potentials. Proteins 65:392\u2013406","journal-title":"Proteins"},{"key":"241_CR24","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1172\/JCI62891","volume":"123","author":"A Li","year":"2013","unstructured":"Li A, Yang Y, Gao C, Lu J, Jeong HW, Liu BH, Tang P, Yao X, Neuberg D, Huang G et al (2013) A SALL4\/MLL\/HOXA9 pathway in murine and human myeloid leukemogenesis. J Clin Invest 123:4195\u20134207","journal-title":"J Clin Invest"},{"key":"241_CR25","first-page":"E7119","volume":"115","author":"BH Liu","year":"2018","unstructured":"Liu BH, Jobichen C, Chia CSB, Chan THM, Tang JP, Chung TXY, Li J, Poulsen A, Hung AW, Koh-Stenta X et al (2018) Targeting cancer addiction for SALL4 by shifting its transcriptome with a pharmacologic peptide. Proc Natl Acad Sci USA 115:E7119\u2013E7128","journal-title":"Proc Natl Acad Sci USA"},{"key":"241_CR26","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa2119771","volume":"386","author":"YC Liu","year":"2022","unstructured":"Liu YC, Kwon J, Fabiani E, Xiao Z, Liu YV, Follo MY, Liu J, Huang H, Gao C, Liu J et al (2022) Demethylation and up-regulation of an oncogene after hypomethylating therapy. N. Engl J Med 386:1998\u20132010","journal-title":"N. Engl J Med"},{"key":"241_CR27","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1126\/science.1244917","volume":"343","author":"G Lu","year":"2014","unstructured":"Lu G, Middleton RE, Sun H, Naniong M, Ott CJ, Mitsiades CS, Wong KK, Bradner JE, Kaelin Jr WG (2014) The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins. Science 343:305\u2013309","journal-title":"Science"},{"key":"241_CR28","doi-asserted-by":"crossref","first-page":"2726","DOI":"10.1182\/blood-2006-02-001594","volume":"108","author":"Y Ma","year":"2006","unstructured":"Ma Y, Cui W, Yang J, Qu J, Di C, Amin HM, Lai R, Ritz J, Krause DS, Chai L (2006) SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic mice. Blood 108:2726\u20132735","journal-title":"Blood"},{"key":"241_CR29","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","volume":"341","author":"D Martinez Molina","year":"2013","unstructured":"Martinez Molina D, Jafari R, Ignatushchenko M, Seki T, Larsson EA, Dan C, Sreekumar L, Cao Y, Nordlund P (2013) Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay. Science 341:84\u201387","journal-title":"Science"},{"key":"241_CR30","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3390\/cells9040883","volume":"9","author":"D Masso-Valles","year":"2020","unstructured":"Masso-Valles D, Soucek L (2020) Blocking Myc to treat cancer: reflecting on two decades of omomyc. Cells 9:883","journal-title":"Cells"},{"key":"241_CR31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41594-020-0405-9","volume":"27","author":"ME Matyskiela","year":"2020","unstructured":"Matyskiela ME, Clayton T, Zheng X, Mayne C, Tran E, Carpenter A, Pagarigan B, McDonald J, Rolfe M, Hamann LG et al (2020) Crystal structure of the SALL4-pomalidomide-cereblon-DDB1 complex. Nat Struct Mol Biol 27:319\u2013322","journal-title":"Nat Struct Mol Biol"},{"key":"241_CR32","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/s41589-018-0129-x","volume":"14","author":"ME Matyskiela","year":"2018","unstructured":"Matyskiela ME, Couto S, Zheng X, Lu G, Hui J, Stamp K, Drew C, Ren Y, Wang M, Carpenter A et al (2018) SALL4 mediates teratogenicity as a thalidomide-dependent cereblon substrate. Nat Chem Biol 14:981\u2013987","journal-title":"Nat Chem Biol"},{"key":"241_CR33","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.3390\/cells11162601","volume":"11","author":"S Moein","year":"2022","unstructured":"Moein S, Tenen DG, Amabile G, Chai L (2022) SALL4: an intriguing therapeutic target in cancer treatment. Cells 11:2601","journal-title":"Cells"},{"key":"241_CR34","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.molcel.2020.11.046","volume":"81","author":"R Pantier","year":"2021","unstructured":"Pantier R, Chhatbar K, Quante T, Skourti-Stathaki K, Cholewa-Waclaw J, Alston G, Alexander-Howden B, Lee HY, Cook AG, Spruijt CG et al (2021) SALL4 controls cell fate in response to DNA base composition. Mol Cell 81:845\u2013858.e848","journal-title":"Mol Cell"},{"key":"241_CR35","doi-asserted-by":"crossref","first-page":"e1009818","DOI":"10.1371\/journal.pcbi.1009818","volume":"18","author":"E Porta-Pardo","year":"2022","unstructured":"Porta-Pardo E, Ruiz-Serra V, Valentini S, Valencia A (2022) The structural coverage of the human proteome before and after AlphaFold. PLoS Comput Biol 18:e1009818","journal-title":"PLoS Comput Biol"},{"key":"241_CR36","doi-asserted-by":"crossref","first-page":"10173","DOI":"10.1073\/pnas.180290497","volume":"97","author":"EM Rego","year":"2000","unstructured":"Rego EM, He LZ, Warrell Jr. RP, Wang ZG, Pandolfi PP (2000) Retinoic acid (RA) and As2O3 treatment in transgenic models of acute promyelocytic leukemia (APL) unravel the distinct nature of the leukemogenic process induced by the PML-RARalpha and PLZF-RARalpha oncoproteins. Proc Natl Acad Sci USA 97:10173\u201310178","journal-title":"Proc Natl Acad Sci USA"},{"key":"241_CR37","volume":"298","author":"W Ru","year":"2022","unstructured":"Ru W, Koga T, Wang X, Guo Q, Gearhart MD, Zhao S, Murphy M, Kawakami H, Corcoran D, Zhang J et al (2022) Structural studies of SALL family protein zinc finger cluster domains in complex with DNA reveal preferential binding to an AATA tetranucleotide motif. J Biol Chem 298:102607","journal-title":"J Biol Chem"},{"key":"241_CR38","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nature04710","volume":"440","author":"MC Sanguinetti","year":"2006","unstructured":"Sanguinetti MC, Tristani-Firouzi M (2006) hERG potassium channels and cardiac arrhythmia. Nature 440:463\u2013469","journal-title":"Nature"},{"key":"241_CR39","unstructured":"Schr\u00f6dinger (2020a) Glide. Schr\u00f6dinger Release 2020-2"},{"key":"241_CR40","unstructured":"Schr\u00f6dinger (2020b) Ligprep. Schr\u00f6dinger Release 2020-2"},{"key":"241_CR41","unstructured":"Schr\u00f6dinger (2020c) Protein Preparation Wizard. Schr\u00f6dinger Release 2020-2"},{"key":"241_CR42","unstructured":"Schr\u00f6dinger (2020d) SiteMap. Schr\u00f6dinger Release 2020-2"},{"key":"241_CR43","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/pro.3290","volume":"27","author":"F Sievers","year":"2018","unstructured":"Sievers F, Higgins DG (2018) Clustal Omega for making accurate alignments of many protein sequences. Protein Sci 27:135\u2013145","journal-title":"Protein Sci"},{"key":"241_CR44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/msb.2011.75","volume":"7","author":"F Sievers","year":"2011","unstructured":"Sievers F, Wilm A, Dineen D, Gibson TJ, Karplus K, Li W, Lopez R, McWilliam H, Remmert M, Soding J et al (2011) Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega. Mol Syst Biol 7:539","journal-title":"Mol Syst Biol"},{"key":"241_CR45","doi-asserted-by":"crossref","first-page":"eaat0572","DOI":"10.1126\/science.aat0572","volume":"362","author":"QL Sievers","year":"2018","unstructured":"Sievers QL, Petzold G, Bunker RD, Renneville A, Slabicki M, Liddicoat BJ, Abdulrahman W, Mikkelsen T, Ebert BL, Thoma NH (2018) Defining the human C2H2 zinc finger degrome targeted by thalidomide analogs through CRBN. Science 362:eaat0572","journal-title":"Science"},{"key":"241_CR46","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1158\/1078-0432.CCR-09-0343","volume":"15","author":"TA Soucy","year":"2009","unstructured":"Soucy TA, Smith PG, Rolfe M (2009) Targeting NEDD8-activated cullin-RING ligases for the treatment of cancer. Clin Cancer Res 15:3912\u20133916","journal-title":"Clin Cancer Res"},{"key":"241_CR47","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1053\/j.gastro.2019.08.022","volume":"157","author":"JL Tan","year":"2019","unstructured":"Tan JL, Li F, Yeo JZ, Yong KJ, Bassal MA, Ng GH, Lee MY, Leong CY, Tan HK, Wu CS et al (2019) New high-throughput screening identifies compounds that reduce viability specifically in liver cancer cells that express high levels of SALL4 by inhibiting oxidative phosphorylation. Gastroenterology 157:1615\u20131629.e1617","journal-title":"Gastroenterology"},{"key":"241_CR48","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.gene.2016.02.019","volume":"584","author":"H Tatetsu","year":"2016","unstructured":"Tatetsu H, Kong NR, Chong G, Amabile G, Tenen DG, Chai L (2016) SALL4, the missing link between stem cells, development and cancer. Gene 584:111\u2013119","journal-title":"Gene"},{"key":"241_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.semcancer.2019.10.002","volume":"60","author":"Y Verhoeven","year":"2020","unstructured":"Verhoeven Y, Tilborghs S, Jacobs J, De Waele J, Quatannens D, Deben C, Prenen H, Pauwels P, Trinh XB, Wouters A et al (2020) The potential and controversy of targeting STAT family members in cancer. Semin Cancer Biol 60:41\u201356","journal-title":"Semin Cancer Biol"},{"key":"241_CR50","doi-asserted-by":"publisher","unstructured":"Vu KAL, Kumari K, Liu BH, Gao C, Li F, Tang JP, Maddalo D, Auld DS, Casalena DE, Tian X et al (2023) SALL4B, not targeted by IMiD, is important for SALL4-mediated tumorigenesis. Preprint at https:\/\/doi.org\/10.1101\/2024.01.03.574032","DOI":"10.1101\/2024.01.03.574032"},{"key":"241_CR51","doi-asserted-by":"crossref","first-page":"e202201588","DOI":"10.26508\/lsa.202201588","volume":"6","author":"JA Watson","year":"2023","unstructured":"Watson JA, Pantier R, Jayachandran U, Chhatbar K, Alexander-Howden B, Kruusvee V, Prendecki M, Bird A, Cook AG (2023) Structure of SALL4 zinc finger domain reveals link between AT-rich DNA binding and Okihiro syndrome. Life Sci Alliance 6:e202201588","journal-title":"Life Sci Alliance"},{"key":"241_CR52","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.3892\/or.2016.4545","volume":"35","author":"M Yang","year":"2016","unstructured":"Yang M, Xie X, Ding Y (2016) SALL4 is a marker of poor prognosis in serous ovarian carcinoma promoting invasion and metastasis. Oncol Rep 35:1796\u20131806","journal-title":"Oncol Rep"},{"key":"241_CR53","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1056\/NEJMoa1300297","volume":"368","author":"KJ Yong","year":"2013","unstructured":"Yong KJ, Gao C, Lim JS, Yan B, Yang H, Dimitrov T, Kawasaki A, Ong CW, Wong KF, Lee S et al (2013) Oncofetal gene SALL4 in aggressive hepatocellular carcinoma. N Engl J Med 368:2266\u20132276","journal-title":"N Engl J Med"}],"container-title":["EMBO Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1038\/s44321-025-00241-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1038\/s44321-025-00241-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T13:57:12Z","timestamp":1786975032000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1038\/s44321-025-00241-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,12]]}},"alternative-id":["241"],"URL":"https:\/\/doi.org\/10.1038\/s44321-025-00241-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.01.03.574032","asserted-by":"object"}]},"ISSN":["1757-4676","1757-4684"],"issn-type":[{"value":"1757-4676","type":"print"},{"value":"1757-4684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"assertion":[{"value":"7 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure and competing interests statement"}}],"article-number":"11"}}